Olympus Announces Distribution Partnership with MacroLux Medical for Single-Use Urology Products

• Share:

The agreement includes multiple single-use cystoscopes, ureteroscopes and suction access sheaths. These devices are used to access and visualize the bladder and urinary tract to diagnose and treat urinary diseases and disorders such as kidney stones.

"We are excited to embark on this new partnership, a synergy that underscores our unwavering commitment to advancing patient care," said Gabriel McHugh, Executive Vice President Surgical and Interventional Solutions, Olympus Corp. "By integrating innovative single-use technology into our urology portfolio, we are enhancing the landscape of urological care for our customers and their patients."

Olympus delivers a broad range of kidney and bladder stone management and non-muscular invasive bladder cancer (NMIBC) visualization and access solutions for detection and treatment. With the addition of the MacroLux Medical single-use endoscope and access sheath portfolio, Olympus can offer physicians increased flexibility and confidence in visualization and surgical precision.

"Olympus is a trusted endoscopy partner for treatment of urological disease and now is uniquely positioned to provide access to a broad range of high-quality endoscopes. This includes reusable and single-use flexible scopes, rigid and semi-rigid scopes, powerful lithotripsy solutions, and gold-standard NMIBC detection," said Glen Branconier, Senior Vice President & General Manager of Urology/Gynecology, Olympus Corp. "We are excited and privileged to provide urologists and health care providers with the tools they need to confidently care for their patients."

The agreement includes distribution in the United States, Canada, countries across Europe and countries in the Asia Pacific region. Countries in Europe include: UK (England, Scotland, Wales and Northern Ireland), Ireland, Germany, Austria, Switzerland, Belgium, Netherlands, Norway, Denmark, Sweden, and Luxembourg.

"Olympus is a highly respected industry leader that we deeply admire. Our strategic cooperation with Olympus generates powerful synergies, enabling us to combine our respective strengths and accelerate the market introduction of MacroLux's urological disposable endoscopes and access sheath solutions, products that offer clinical value," said Martin Zhang, Chief Executive Officer, MacroLux Medical. "These products may enhance clinical efficiency and help improve patient treatment outcomes. This collaboration also inspires us to continue with product innovation and R&D, delivering clinical solutions to customers worldwide."

The MacroLux single-use cystoscopes offer the following features:

• 140° field of view
• 235° up/145° down distal tip angulation
• 14.4Fr outer diameter with 2.2mm working channel
• The MacroLux single-use ureteroscopes offer the following features:

The MacroLux single-use ureteroscopes offer the following features:

• 7.5Fr and 8.25Fr outer diameter scope offering
• 275° distal tip angulation
• AutoHold Technology thumb lever control
• 120° field of view The MacroLux single-use suction access sheaths are available in multiple sizes to meet various urological procedure needs and negative pressure connection for stone removal. As with any medical device, careful consideration should be given to all applicable labeling, including potential risks and benefits associated with the product. Visit the Olympus urology product page for more information about Olympus' complete urology portfolio.

The MacroLux single-use suction access sheaths are available in multiple sizes to meet various urological procedure needs and negative pressure connection for stone removal. As with any medical device, careful consideration should be given to all applicable labeling, including potential risks and benefits associated with the product. Visit the Olympus urology product page for more information about Olympus' complete urology portfolio.

About Olympus

At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states.

For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world.

Olympus Europa, headquartered in Hamburg, Germany, serves the EMEA (Europe, Middle East, Africa) Region and employs 7,600 people in 29 countries. For more information, visit https://www.olympus-europa.com and follow our LinkedIn account.

Contact

Matthias Gengenbach

Head of Corporate Communications EMEA
Olympus Europe SE & Co. KG

Press Release | 10/14/2024 Olympus Announces CE Approval for Three Cloud-based AI Medical Devices and Announces Plans for Launch of AI-Powered Endoscopy Ecosystem in 2025

Press Release | 07/18/2024 Enhancing Diagnostic Confidence for Hepato-Pancreato-Biliary Pathologies: Olympus announces Availability for Purchase of Aplio i800 EUS in Europe